News & analysis on the clinical development and manufacture of large molecule drugs
By Natalie Morrison
- Last updated on
Most recently, Riccardo was the lead director on the board of Dionex – recently acquired by Thermo Fisher for in a $2B deal.
Of his appointment to BioScale, he said: “The Company is poised to make substantial contributions to protein research. Its cutting edge technology is a scientific breakthrough which has the ability to change the paradigm for protein measurement across the drug development and diagnostic industries.”